Immunotherapy Flashcards

1
Q

Corticosteroids MOA

A

Inhibits T cell proliferations, cytokine response, decreases response to antibodies, decreases spleen size/content. Broad spectrum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Corticosteroid use

A

organ transplants, chronic immunosuppressant, prevent adverse reactions to drugs, topically.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Corticosteroid toxicity

A

cushings syndrome, suppressed pituitary-hypothalamic axis, osteoporosis, ulcers, menstrual and reproductive issues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cyclosporine MOA

A

Binds to cyclophilin to inhibit calcineurin/T-cell activation to decrease the formation of IL-2. Selective for T-lymphocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cyclosporine characteristics

A

No bone marrow suppression, metabolized by CYP3A4 (drug interactions!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CYP3A4 Inducers

A

Phenobarbitol, phenytoin, Rifampin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CYP3A4 Inhibitors

A

Grape fruit juice, erythromycin, ketoconazole and verapamil.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cyclosporine uses

A

Prevents organ rejection (with corticosteroids or azathioprine), organ transplant maintenance, autoimmune diseases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cyclosporine toxicity

A

nephrotoxic, gingival hyperplasia (need good oral hygeine, HTN, tremors, hirsutism, hyperlipidemia, hyperglycemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tacrolimus (FK506) MOA

A

Similar to cyclosporine but less toxic. Inhibits T cell activation and decreases IL2 and IL4. Narrow therapeutic range. Metabolized by CYP3A4.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tacrolimus (FK506) uses

A

Prevent rejection especially in liver and heart transplants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tacrolimus (FK506) toxicity

A

nephrotoxic, HTN, hyperglycemia, HA, tremors, insomnia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sirolimus MOA

A

Inhibits proliferation of T and B cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sirolimus uses

A

No renal toxicity so used in kidney transplants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sirolimus toxicity

A

increased cholesterol and triglycerides.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pimecrolimus uses

A

Cream for atopic dermatitis that doesn’t cause skin atrophy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Mycophenolate-Mofetil MOA

A

Decreases DNA synthesis by inhibiting monophosphate dehydrogenase that only T and B cells need for purine synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mycophenolate-Mofetil Uses

A

Does NOT suppress bone marrow. Often combined with Tacrolimus to prevent transplant rejection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Mycophenolate-Mofetil toxicity

A

Rash, GI, very high risk of infections.

20
Q

Thalidomide MOA

A

blocks TNF alpha.

21
Q

Thalidomide uses

A

prevents graft versus host reaction

22
Q

Thalidomide toxicity

A

TERATOGENIC. Drowsiness and neutropenia.

23
Q

Azathioprine MOA

A

Prodrug that is converted into 6-mercaptopurine which inhibits purine synthesis.

24
Q

Azathioprine uses

A

Cancer (high doses), prevents rejection, glomerulonephritis in lupus, severe RA, dentists use in place of steroids.

25
Azathioprine toxicity
Myelosuppression, hepatotoxicity, teratogenic, metabolized by xanthine oxidase (allopurinol).
26
Cyclophosphamide MOA
Effects T and B cells. Blocks new antigens and can inhibit an established immune response (treat a rejection attack).
27
Cyclophosphamide toxicity
hemorrhagic cystitis (treat with MESNA and hydration).
28
Methotrexate MOA
Human dihydrofolate reductase inhibitor.
29
Methotrexate uses
psoriasis, antineoplastic, severe RA and asthma.
30
Methotrexate toxicity
hepatotoxicity and teratogenic.
31
Daclizumab/Basiliximab MOA
Binds IL2 receptors on activated T cells to inhibit IL2 activation.
32
Daclizumab/Basiliximab uses
great for kidney transplants. No side effects. No general immunosuppression.
33
Bevacizumab/ranibizumab and Degaptanib/aflibercept MOA
Bind VEGF-A to inhibit angiogenesis. Used in macular degeneration.
34
Interleukin 2 MOA
Immunomodulator that increases the proliferation and differentiation of helper T and cytotoxic T cells.
35
Interleukin 2 Uses
renal cell carcinoma and malignant melanoma.
36
Interleukin 2 toxicity
pulmonary edema, hypotension, hematological.
37
Filgrastim (neupogen) MOA
granulocyte colony stimulation factor for severe neutropenia. Given as subcutaneous depot
38
Filgrastim (neupogen) Toxicity
bone pain (making new marrow).
39
Epoetin-alfa (procrit; epogen) MOV
EPO for severe anemia caused by zidovudine, interleukin, chemo or kindey disease. subcutaneaous depot.
40
Epogen toxicity
HTN and thrombosis/stoke.
41
Interferon alpha and beta
respond to viruses
42
Interferon gamma
activates T lymphocytes and NK cells. Activates macrophages.
43
interferon alfa-2b
Used with Hep C and uveitis
44
Interferon beta-1B
multiple sclerosis.
45
Glatiramer
Multiple sclerosis. acts as decoy. antibodies bind the drug instead of the nerves.
46
Fingolimod
Multiple sclerosis. decreases lymphocytes to reduce the autoimmune response.
47
Dimethyl fumarate
Multiple sclerosis. reduces inflammation.